Trial · NCT05178953
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | sperm concentration | 1 day | count of sperm(In per million - with the help of a neobar slide and microscopic observation |
| Primary | spem motility | 1 day | motility of sperm: Calculate the percentage of motile sperm using microscopic observation |
| Primary | sperm morphology | 1 day | Calculate the percentage of sperm with a normal shape with the help of Papanic staining |
| Primary | lipid proxidation | One week | Malondialdehyde (nmol/mL), is measured using related experimental kits |
| Primary | reactive oxygen species | One week | eactive oxygen species (ROS (RLU/s)), is measured using related experimental kits |
| Primary | total antioxidant capacity | One week | total antioxidant capacity (TAC (/m / l)) is measured using related experimental kits |
| Primary | FSH hormon | One week | FSH (IU / L) is measured from the blood serum of volunteers using ELISA kit |
| Primary | LH hormon | One week | LH (IU / L) is measured from the blood serum of volunteers using ELISA kit |
| Primary | testosteron hormon [ Time Frame: One week after starting the medication ] testosterone | One week | testosterone (nanomolar per liter) is measured from the blood serum of volunteers using ELISA kit |
| Primary | (Tissue necrosis Factor) | One week | TNF α( Tissue necrosis Factor) (pg/mL) as an inflammatory factor is measured using related experimental kit |
| Primary | interleukin-6 | One week | interleukin-6 (IL-6)/(pg/mL) as an inflammatory factor is measured using related experimental kit |
| Primary | Sperm DNA Fragmentation Assay(SDFA) | One week | DNA fragmentation is assessed using an SDFA kit and microscopic observations (as a percentage of damaged sperm). |
| Secondary | BAX expression | 3 month | BAX expression \[ Time Frame: 3 months \] expression of BAX gen(in p.c) using real-time PCR and Western blot |
| Secondary | Bcl2 expression | 3 months | Bcl-2 gen(in p.c) using real-time PCR and Western blot |
| Secondary | caspase 3 expression | 3 months | expression of caspase 3 gen(in p.c) using real-time PCR and Western blot |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05178953/registered